AAAAAA
Results:
1-15
|
Results: 15
Authors:
Bosly, A
Haioun, C
Gisselbrecht, C
Reyes, F
Coiffier, B
Citation: A. Bosly et al., High-dose treatment with autologous stem cell transplantation versus sequential chemotherapy: the GELA experience, EUR J HAEMA, 66, 2001, pp. 3-7
Authors:
Cazals-Hatem, D
Andre, M
Mounier, N
Copin, MC
Divine, M
Berger, F
Bosly, A
Kerneis, Y
Briere, J
Quesnel, B
Diebold, J
Gaulard, P
Citation: D. Cazals-hatem et al., Pathologic and clinical features of 77 Hodgkin's lymphoma patients treatedin a lymphoma protocol (LNH87) - A GELA study, AM J SURG P, 25(3), 2001, pp. 297-306
Authors:
Sonet, A
Hustin, J
De Coene, B
Gilliard, C
Gustin, T
Doyen, C
Vandenbossche, L
Jost, E
Robin, V
Chatelain, B
Bosly, A
Citation: A. Sonet et al., Unusual growth within a meningioma (leukemic infiltrate), AM J SURG P, 25(1), 2001, pp. 127-130
Authors:
Boogaerts, MA
Maertens, J
Van der Geest, R
Bosly, A
Michaux, JL
Van Hoof, A
Cleeren, M
Wostenborghs, R
De Beule, K
Citation: Ma. Boogaerts et al., Pharmacokinetics and safety of a 7-day administration of intravenous itraconazole followed by a 14-day administration of itraconazole oral solution in patients with hematologic malignancy, ANTIM AG CH, 45(3), 2001, pp. 981-985
Authors:
Bosly, A
Gisselbrecht, C
Citation: A. Bosly et C. Gisselbrecht, Intensification with autologous transplantation in non-Hodgkin's lymphomas, B CANCER, 88(9), 2001, pp. 877-887
Authors:
Lubbert, M
Wijermans, P
Kunzmann, R
Verhoef, G
Bosly, A
Ravoet, C
Andre, M
Ferrant, A
Citation: M. Lubbert et al., Cytogenetic responses in high-risk myelodysplastic syndrome following low-dose treatment with the DNA methylation inhibitor 5-aza-2 '-deoxycytidine, BR J HAEM, 114(2), 2001, pp. 349-357
Authors:
Van den Neste, E
Louviaux, I
Michaux, JL
Delannoy, A
Michaux, L
Sonet, A
Bosly, A
Doyen, C
Mineur, P
Andre, M
Straetmans, N
Coche, E
Venet, C
Duprez, T
Ferrant, A
Citation: E. Van Den Neste et al., Phase I/II study of 2-chloro-2 '-deoxyadenosine with cyclophosphamide in patients with pretreated B cell chronic lymphocytic leukemia and indolent. non-Hodgkin's lymphoma, LEUKEMIA, 14(6), 2000, pp. 1136-1142
Authors:
Tilly, H
Mounier, N
Lederlin, P
Briere, J
Dupriez, B
Sebban, C
Bosly, A
Biron, P
Nouvel, C
Herbrecht, R
Bordessoule, D
Coiffier, B
Citation: H. Tilly et al., Randomized comparison of ACVBP and m-BACOD in the treatment of patients with low-risk aggressive lymphoma: The LNH87-1 study, J CL ONCOL, 18(6), 2000, pp. 1309-1315
Authors:
Wijermans, P
Lubbert, M
Verhoef, G
Bosly, A
Ravoet, C
Andre, M
Ferrant, A
Citation: P. Wijermans et al., Low-dose 5-aza-2 '-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: A multicenter phase II study in elderly patients, J CL ONCOL, 18(5), 2000, pp. 956-962
Authors:
Haioun, C
Lepage, E
Gisselbrecht, C
Salles, G
Coiffier, B
Brice, P
Bosly, A
Morel, P
Nouvel, C
Tilly, H
Lederlin, P
Sebban, C
Briere, J
Gaulard, P
Reyes, F
Citation: C. Haioun et al., Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: Final analysis of the prospective LNH87-2 protocol - A Groupe d'Etude des Lymphomes de l'Adulte Study, J CL ONCOL, 18(16), 2000, pp. 3025-3030
Authors:
Jacquy, C
Soree, A
Lambert, F
Bosly, A
Ferrant, A
Andre, M
Parma, J
Kentos, A
Martiat, P
Citation: C. Jacquy et al., A quantitative study of peripheral blood stem cell contamination in diffuse large-cell non-Hodgkin's lymphoma: one-half of patients significantly mobilize malignant cells, BR J HAEM, 110(3), 2000, pp. 631-637
Authors:
Young, GAR
Bosly, A
Gibbs, DL
Durrant, S
Citation: Gar. Young et al., A double-blind comparison of fluconazole and nystatin in the prevention ofcandidiasis in patients with leukaemia, EUR J CANC, 35(8), 1999, pp. 1208-1213
Authors:
Jacquy, C
Lambert, F
Soree, A
Van Daele, S
Heusterspreute, M
Bosly, A
Ferrant, A
Parma, J
Bron, D
Martiat, P
Citation: C. Jacquy et al., Peripheral blood stem cell contamination in mantle cell non-Hodgkin lymphoma: the case for purging?, BONE MAR TR, 23(7), 1999, pp. 681-686
Myelodysplastic syndrome with monosomy 5 and/or 7 following therapy with 2-chloro-2 '-deoxyadenosine
Authors:
Van Den Neste, E
Louviaux, I
Michaux, JL
Delannoy, A
Michaux, L
Hagemeijer, A
Scheiff, JM
Bosly, A
Straetmans, N
Ferrant, A
Citation: E. Van Den Neste et al., Myelodysplastic syndrome with monosomy 5 and/or 7 following therapy with 2-chloro-2 '-deoxyadenosine, BR J HAEM, 105(1), 1999, pp. 268-270
Authors:
Delannoy, A
Van den Neste, E
Michaux, JL
Bosly, A
Ferrant, A
Citation: A. Delannoy et al., Cladribine for Waldenstrom's macroglobulinaemia, BR J HAEM, 104(4), 1999, pp. 933-934
Risultati:
1-15
|